During the last few decades, the antimicrobial properties of plant extracts have been intensively investigated, as the demand for safe drugs has increased owing to the misuse of antibiotic chemicals and an increase of immune deficiency [7, 23] . For example, various plants, such as Scutellaria baicalensis, Coptis chinesis, and Syzygium aromaticum, have been used to treat a wide range of microbial infections, and recently baicalein [21] , berberine [28] , and eugenol [19] were purified from these plants, respectively. These compounds are considered as safe and potent antimicrobial agents [19, 21] .
Broussonetia papyrifera (L.) Vent. (Moraceae), a paper mulberry, is a well-known tree in eastern Asian countries including Korea, Japan, Taiwan, and China. In Korea, this tree reaches a height of 12 m, but in practice it is usually harvested at much shorter height when the stems are about 2.5 cm in diameter and 3-4 m tall to make high-quality paper or cloth. The fruit is edible and sweet and, together with the leaves, is used as a tonic in Korea. The barks and roots have many medicinal uses. In the root barks of B. papyrifera, benzofurans, biphenylpropanoids, coumarins, and various types of flavonoids (chalcones, flavans, flavanones, and flavones) were identified [3, 11, 14] . Therefore, it is natural that the extract of root barks has been used as traditional medicine to treat microbial infection, abdominal dropsy, ascites, and menorrhagia [9, 20] . Recently, antiinflammation [4, 17] , antioxidative [18, 25] , α-glucosidase [22] , and tyrosinase inhibitory activities [8, 12, 16] were also reported from the root barks of B. papyriferra.
Our group has previously reported a prenylated flavonoid, papyriflavonol A [PapA: 5,7,3',4'-tetrahydroxy-6,5'-di-(γ,γ-dimethylallyl)-flavonol, C 21 H 22 O 5 ], isolated from the root barks of B. papyrifera [24] . PapA showed strong antiinflammatory and anti-allergic activities by inhibition of 5-lipoxygenase and 12-lipoxygenase [5] , passive cutaneous anaphylaxis reaction, and inhibition of secretory phospholipase A 2 [13] . Recently, we reported strong antimicrobial activities of PapA against different pathogenic bacteria and fungi [23] . However, the details of antifungal activity against Candida albicans, an opportunistic human pathogen, remain unknown. In this study, we investigated the fungicidal mechanism of PapA using C. albicans and Saccharomyces cerevisiae to substantiate its antimicrobial action. The experimental results in fungicidal kinetics, plasma membrane All chemicals and solvents used in the column chromatography and the assays were of reagent grade and were purchased from commercial sources.
Isolation and Identification of PapA
PapA, a prenylated flavonoid, was isolated from the root bark of B. papyrifera (L.) Vent. based on methods in a previous report [24] . The purity of the isolated compound evaluated by reversed-phase high-performance liquid chromatography (HPLC) was above 98% (w/w). The structure of PapA was identified as previously described [24] , and is shown in Fig. 1 .
Antifungal Activity
Fungal cells to be tested were grown in Sabouraud dextrose broth (Difco Co.) at 30 o C, and MICs were determined by a serial 2-fold dilution of test compounds, following the recommendations of the Clinical and Laboratory Standards Institute [10] . The culture with dimethylsulfoxide (0.5%) was used as a solvent control, and the cultures supplemented with ampicillin, erythromycin, amphotericin B, miconazole, or 5-flurocytosine were used as positive controls, respectively. The MIC was defined as the lowest concentration able to inhibit any visible microorganism growth and was determined by measuring the cell growth OD after 48 h cultivation. The minimum fungicidal concentration (MFC) was determined by culturing 0.1 ml of the culture broth from all tubes in the MIC assay on Sabouraud dextrose agar plates at 30 o C for 48 h. The MFC was defined as the lowest concentration at which growth of fungal colony was completely inhibited [23] . All data are presented as the mean values of triplicates for each microorganism.
Measurement of Plasma Membrane Fluorescence Anisotropy
Anisotropy of fluorescence from exponentially growing C. albicans or S. cerevisiae cells labeled by 1,6-diphenyl-1,3,5-hexatriene (DPH; Molecular Probes, Inc., Eugene, OR, U.S.A.) was used to monitor changes in membrane dynamics. The 1×10 M DPH, followed by three washings in PBS buffer. Steady-state fluorescence anisotropy was measured using a fluorescence spectrometer (Hitachi F-4500; Tokyo, Japan) at 350 nm excitation and 425 nm emission wavelengths [6] .
Scanning Electron Microscopy
Mid-log phase C. albicans or S. cerevisiae were suspended at 10 8 CFU/ml in 50 mM phosphate buffer (pH 7.4), and incubated at 30 o C with different concentrations of PapA. After 2 h, the cells were fixed with an equal volume of 5% glutaraldehyde and 1% paraformaldehyde in 0.2 M Na-cacodylate buffer (pH 7.2). After fixation for 2 h at 4 o C, the samples were filtered on isopore filters (0.2 mm pore size; Millipore, Bedford, MA, U.S.A.) and extensively washed with 0.1 M Na-cacodylate buffer (pH 7.2). The filters were then treated with 1% osmium tetroxide, washed with 5% sucrose in cacodylate buffer, and subsequently dehydrated with 50%, 60%, 70%, 90%, 95%, and 100% ethanol. After lyophilization and gold coating, the samples were examined by scanning electron microscopy (Hitachi S-2500C; Tokyo, Japan).
Hemolytic Activity Against Human Erythrocytes
The hemolytic activity of PapA was evaluated by determining the release of hemoglobin from a 4% suspension of fresh erythrocytes at 414 nm with an ELISA plate reader [27] . Hemolytic ratios 0% and 100% were determined in DMSO (2%)-containing PBS and 0.1% Triton X-100, respectively. The hemolytic percentage was calculated using the following equation. 
Hemolysis(%)=[(OD

RESULTS AND DISCUSSION
Antimicrobial Activity of PapA
The MIC values of PapA against fungi, Gram-negative bacteria, and Gram-positive bacteria were measured and compared with those for commercial antibiotics (Table 1) . 
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Ampicillin and erythromycin as antibacterial agents, and amphotericin B and miconazole as antifungal agents, showed strong growth inhibitions with 1.25 µg/ml of MIC against the test strains. However, S. epidermidis, S. typhimurim, and C. albicans showed resistance against ampicillin, erythromycin, and 5-fluorocytosine, respectively. However, PapA showed strong antibacterial and antifungal activities with 10~25 µg/ml of MIC, irrespective of the tested strains. In addition, the MFC values were the same as the MIC values of PapA for the fungi (data not shown). Although the susceptibilities of different strains by PapA treatments were varied and the MIC values of PapA were higher than those of commercial antibiotics, these results suggested that PapA acts as a broad-spectrum antimicrobial agent and could be applied to control antibiotic-resistant pathogens.
The growth inhibitions of C. albicans, and S. cerevisiae by PapA were measured to elucidate its antifungal mechanism (Fig. 2) . Without treatment, the culture of S. cerevisiae cell population rapidly increased and reached a maximum OD of 1.1 within 18 h. Treatment of 25 µg/ml of PapA to S. cerevisiae showed a minor and transient increase of cell OD from 0.19 to 0.29 during the initial 5 h. After 10 h of cultivation, the cell OD decreased and was maintained to 0.18 at 15 h (Fig. 2A) . These patterns were evident in treatment of 50 µg/ml of PapA. The cell OD in the 15 h culture decreased to 0.05. In C. albicans, without treatment of PapA, the cells grew rapidly and reached maximal growth at 19 h. Treatment of 25 or 50 µg/ml of PapA decreased the cell OD from 0.19 to 0.12~0.13 without transient growth, as shown for S. cerevisiae, and was maintained at 0.09~0.12 up to 25 h cultivation (Fig. 2B) . These results imply that PapA has strong antifungal activity mediated by cell lysis, although the susceptible fungal cell states are varied.
Effect of PapA on Fungal Cell Membrane Integrity
Using scanning electron microscopy, the effects of PapA on the fungal cell surface were investigated. In S. cerevisiae and C. albicans, control cells in the absence of PapA showed a regular, smooth surface (Fig. 3) . In contrast, cells treated with PapA (12.5-50 µg/ml) revealed severe detrimental effects on the morphology of cells, showing disruption of the membrane integrity. Treatment of PapA showed large surface collapse and wrinkled abnormalities of cell morphology along with small clefts. These morphological features in cells might be due to alteration of the cell wall and membrane, which results from the lysis of the cell membrane with release of inner cell materials [1, 2] . To confirm the antifungal mechanism of PapA, DPH was used for monitoring the cell membrane integrity. Since DPH is a membrane fluorescence probe that interacts with an acyl group of lipid bilayers, the membrane lysis and disruption of cells by the treated chemical will result in the decrease of fluorescence in DPH-treated cells [15] . As shown in Fig. 4 , the plasma membrane DPH fluorescence anisotropy was decreased by treatment with PapA and the decrease was dependent on PapA concentrations. These results suggested that the antifungal activity of PapA is mediated by its ability to disrupt membrane integrity.
Hemolytic Activity of PapA Against Human RBC Many antifungal agents including amphotericin B have limitation in clinical use because of their harmful effects on human erythrocytes. Since PapA acts as a membrane disruptor, the hemolytic activity of PapA was evaluated using human red blood cells. As shown in Fig. 5A , treatment of amphotericin B to human red blood cells resulted in severe hemolysis. The hemolysis ratio was above 53% even at a low concentration of 6.3 µg/ml, and 90% hemolysis was found in 25 µg/ml, indicating that amphotericn B, a polyene antibiotic that interacts with sterols in the cell membranes, has a strong hemolytic toxicity. Meanwhile, treatment of PapA to human red blood cells showed minor hemolysis, below 11% at 63 µg/ ml. As the treatment concentration increased to 125 µg/ml, the hemolysis ratio of PapA was sharply increased to 75%. These results suggested that PapA has a less toxic effect than amphotericin B, and the hemolytic activity is negligible at MIC levels of pathogenic fungi and bacteria. The minor hemolytic activity may be reduced by co- treatment of PapA with commercial antibiotics. In summary, PapA, a prenylated flavonoid isolated from the root barks of B. papyrifera, has strong antibacterial and antifungal activities against pathogenic bacteria and fungi including antibiotic-resistant strains. Although the exact mechanism by which PapA exerts its action has not yet been fully elucidated, our results indicate that the antifungal activity of PapA is more likely to be mediated by its ability to disrupt cell membrane activity. Moreover, treatment of PapA, showing strong antifungal activity, also showed a lower hemolytic ratio against human red blood cells. For practical applications, further research on the inhibitions of biofilm formation and quorum sensing, and on the antifungal activity of PapA against clinically isolated multidrug-resistant C. albicans, is necessary.
